Skip to main content
SpringerLink
Log in

Effects of Specific Angiotensin II Receptor Antagonists on Exercise Tolerance in Chronic Heart Failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995; 38:1-22.

    Google Scholar 

  2. Mancini DM. Pulmonary factors limiting exercise capacity in patients with heart failure. Prog Cardiovasc Dis 1995;37: 347-370.

    Google Scholar 

  3. Packer M, Pitt B. Which objective measurements parallel the course of disease progression in patients with congestive heart failure (abstract). J Am Coll Cardiol 1988;11:202A.

    Google Scholar 

  4. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634-638.

    Google Scholar 

  5. Pilote L, Silberberg J, Lisbona R, et al. Prognosis in patients with low left ventricular ejection fraction after myocardial infarction. Importance of exercise capacity. Circulation 1989;80:1636-1641.

    Google Scholar 

  6. Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 1988;62:1636- 1641.

    Google Scholar 

  7. Higginbotham MB, Morris KG, Conn EH, et al. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983;51: 52-60.

    Google Scholar 

  8. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47: 33-39.

    Google Scholar 

  9. Szlachcic J, Massie BM, Kramer Bl, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55:1037-1042

    Google Scholar 

  10. Cohen-Solal A, Caviezell B. Cardiopulmonary exercise testing in chronic heart failure. Heart Failure 1994;10:46-57.

    Google Scholar 

  11. Wilson JR. Exercise intolerance in heart failure: importance of skeletal muscle. Circulation 1995;91:559-561.

    Google Scholar 

  12. Minotti JR, Christoph I, Massie BM. Skeletal muscle function, morphology and metabolism in patients with chronic heart failure. Chest 1995;101(Suppl 5): 333S-339S.

    Google Scholar 

  13. Lipkin DP, Jones DA, Round JM, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988;18:187-195.

    Google Scholar 

  14. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to bloodflow. Circulation 1988;78:320-326.

    Google Scholar 

  15. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991;84:1597-1607.

    Google Scholar 

  16. Mancini DM, Davis L, Wexler JP, et al. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. J Am Coll Cardiol 1987;10:845-850.

    Google Scholar 

  17. Drexler H, Banhardt U, Meinertz T, et al. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 1989;491- 502.

  18. Lipkin DP, Canepa-Anson R, Stephens MR, et al. Factors determining symptoms in chronic heart failure: comparison of fast and slow exercise tests. Br Heart J 1986;55:439-445.

    Google Scholar 

  19. Remes J, Tikkanen I, Fyhrquist F, et al. Neuroendocrine activity in untreated heart failure. Br Heart J 1991;65:249-255.

    Google Scholar 

  20. Aldiger JC, Huang H, Dalmay F, et al. Angiotensin converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993;21:289-295.

    Google Scholar 

  21. Francis GS, Goldsmith SR, Cohn JR. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982;104:725-731.

    Google Scholar 

  22. Wilson JR, Frey MJ, Mancini DM, et al. Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure. Circulation 1989;79:1021-1027.

    Google Scholar 

  23. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilatation in the peripheral circulation of patients with congestive heart failure. J Am Coll Cardiol 1992; 19:918-925.

    Google Scholar 

  24. Symons JD, Stebbins CL. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J Cardiovasc Pharmacol 1996;28:223-231.

    Google Scholar 

  25. Lang RM, Elkayam U, Yellen LG, et al. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators. J Am Coll Cardiol 1997;30: 983-991.

    Google Scholar 

  26. Klinger G, Jaramillo N, Ikram H, et al. Effects of losartan on exercise capacity, morbidity and mortality in patients with symptomatic heart failure (abstract). J Am Coll Cardiol 1997;29(Suppl A): 205A.

    Google Scholar 

  27. Tonkon M, Awan N, Niazi I, et al. Combination of Irbesartan with conventional therapy, including angiotensin converting enzyme inhibitors in heart failure (abstract P128) Proc Conf Heart Failure ''97 Eur Soc Cardiol.

  28. Nampalli V, Allahdad IA, Marty D, et al. Irbesartan compared with lisinopril in heart failure (abstract P127). Proc Conf Heart Failure '97 Eur Soc Cardiol.

Download references

Author information

Authors and Affiliations

  1. Christchurch Hospital, Christchurch, New Zealand

    Hamid Ikram

Authors
  1. Hamid Ikram
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikram, H. Effects of Specific Angiotensin II Receptor Antagonists on Exercise Tolerance in Chronic Heart Failure. Heart Fail Rev 3, 217–220 (1999). https://doi.org/10.1023/A:1009713618119

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009713618119

Keywords

Search

Navigation